With this notice, Frontiers states its awareness of ethics concerns surrounding the article “Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil” published on 15 February 2022. An investigation is currently being conducted by The Federal University of Health Sciences of Porto Alegre, in accordance with applicable institutional policies and procedures. This expression of concern has been posted while Frontiers awaits the outcome of that investigation. It will be updated accordingly after that time.
Summary
Keywords
COVID-19, SARS-CoV-2, P.1, VOC, Genomic epidemiology, phylogenomics, Spike, Nsp
Citation
Frontiers Editorial Office (2024) Expression of concern on: Comparative genomics and characterization of SARS-CoV-2 P.1 (Gamma) variant of concern from Amazonas, Brazil. Front. Med. 11:1393692. doi: 10.3389/fmed.2024.1393692
Received
29 February 2024
Accepted
11 March 2024
Published
26 March 2024
Approved by
Frontiers in Medicine Editorial Office, Frontiers Media SA, Switzerland
Volume
11 - 2024
Updates
Copyright
© 2024 Frontiers Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office research.integrity@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.